Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

419 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy.
Colombel JF, Hisamatsu T, Atreya R, Bresso F, Thin L, Panaccione R, Parra RS, Ford S, Remple VP, Lacerda AP, Anyanwu SI, Mallick M, Garrison A, Regueiro M. Colombel JF, et al. Among authors: panaccione r. Clin Gastroenterol Hepatol. 2024 Mar 15:S1542-3565(24)00254-4. doi: 10.1016/j.cgh.2024.02.027. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38492903 Free article.
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure.
Peyrin-Biroulet L, Panaccione R, Louis E, Atreya R, Rubin DT, Lindsay JO, Siffledeen J, Lukin DJ, Wright J, Watanabe K, Ford S, Remple VP, Lacerda AP, Dubcenco E, Garrison A, Zhou Q, Berg S, Anyanwu SI, Schreiber S. Peyrin-Biroulet L, et al. Among authors: panaccione r. Clin Gastroenterol Hepatol. 2024 Mar 15:S1542-3565(24)00253-2. doi: 10.1016/j.cgh.2024.02.026. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38492904 Free article.
Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Crohn's Disease in US and Europe: Results from the Cross-Sectional CONFIDE Study.
Schreiber S, Hunter Gibble T, Panaccione R, Rubin DT, Travis S, Hibi T, Potts Bleakman A, Panni T, Favia AD, Kayhan C, Atkinson C, Saxena S, Dubinsky MC. Schreiber S, et al. Among authors: panaccione r. Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08434-5. Online ahead of print. Dig Dis Sci. 2024. PMID: 38700629
Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjects.
Turpin W, Bedrani L, Espin-Garcia O, Xu W, Silverberg MS, Smith MI, Garay JAR, Lee SH, Guttman DS, Griffiths A, Moayyedi P, Panaccione R, Huynh H, Steinhart HA, Aumais G, Dieleman LA, Turner D; CCC IBD GEM Project research team; Paterson AD, Croitoru K. Turpin W, et al. Among authors: panaccione r. BMC Med Genet. 2020 Oct 15;21(1):204. doi: 10.1186/s12881-020-01115-w. BMC Med Genet. 2020. PMID: 33059653 Free PMC article.
Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure.
Panés J, D'Haens GR, Sands BE, Ng SC, Lawendy N, Kulisek N, Guo X, Wu J, Vranic I, Panaccione R, Vermeire S. Panés J, et al. Among authors: panaccione r. United European Gastroenterol J. 2024 May 22. doi: 10.1002/ueg2.12584. Online ahead of print. United European Gastroenterol J. 2024. PMID: 38778549 Free article.
Environmental Factors Associated with Risk of Crohn's Disease Development in the CCC-GEM Project.
Xue M, Leibovitzh H, Jingcheng S, Neustaeter A, Dong M, Xu W, Espin-Garcia O, Griffiths AM, Steinhart AH, Turner D, Huynh HQ, Dieleman LA, Panaccione R, Aumais G, Bressler B, Bitton A, Murthy S, Marshall JK, Hyams JS, Otley A, Bernstein CN, Moayyedi P, El-Matary W, Fich A, Denson LA, Ropeleski MJ, Abreu MT, Deslandres C, Cino M, Avni-Biron I, Lee SH, Turpin W; CCC GEM Project Research Consortium; Croitoru K. Xue M, et al. Among authors: panaccione r. Clin Gastroenterol Hepatol. 2024 May 15:S1542-3565(24)00450-6. doi: 10.1016/j.cgh.2024.03.049. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38759825
Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies.
Sands BE, D'Haens G, Panaccione R, Regueiro M, Ghosh S, Hudesman D, Ahmad HA, Mehra D, Wu H, Jain A, Petersen A, Osterman MT, Afzali A, Danese S. Sands BE, et al. Among authors: panaccione r. Clin Gastroenterol Hepatol. 2024 May 8:S1542-3565(24)00405-1. doi: 10.1016/j.cgh.2024.03.042. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38723981 Free article.
Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn's Disease.
Khanna R, Feagan BG, Zou G, Stitt LW, McDonald JWD, Bressler B, Panaccione R, Shackelton LM, VanViegen T, Loftus EV Jr, Daperno M, Jairath V, D'Haens G, Sandborn WJ. Khanna R, et al. Among authors: panaccione r. Inflamm Bowel Dis. 2024 Apr 25:izae089. doi: 10.1093/ibd/izae089. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38661492
419 results